|
1) Ötles, S., Pire, R. 2001. Fatty acid composition of Chlorella and Spirulina microalgae species. J AOAC Int. 84(6):1708-14.
2) Simpore, J. et al. 2005. Nutrition rehabilitation of HIV-infected and HIV-negative undernourished children utilizing spirulina. Ann Nutr Metab. 49(6):373-80. doi: 10.1159/000088889.
3) Matondo, F. K. et al. 2016. Spirulina Supplements Improved the Nutritional Status of Undernourished Children Quickly and Significantly: Experience from Kisantu, the Democratic Republic of the Congo. International Journal of Pediatrics. 1-5. doi: 10.1155/2016/1296414.
4) Chamorro, G. et al. 2002. Update on the pharmacology of Spirulina (Arthrospira), an unconventional food. Arch Latinoam Nutr. 52(3):232-40.
5) Chamorro, G. et al. 1996. Pharmacology and toxicology of Spirulina alga. Rev Invest Clin. 48(5):389-99.
6) McCarty, M. F. 2007. Clinical potential of Spirulina as a source of phycocyanobilin. J Med Food. 10(4):566-70. doi: 10.1089/jmf.2007.621.
7) Hirahashi, T. et al. 2002. Activation of the innate immune system by Spirulina: augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina patensis. Int Immunopharmacol. 2(4):423-34. doi: 10.1016/S1567-5769(01)00166-7.
8) Blinkova, L. P. et al. 2001. Biological Activity of Spirulina. Zh Mikrobiol Epidemiol Immunobiol. (2):114-8.
9) Wu, Q. et al. 2016. The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: An overview. Arch Toxicol. 90(8):1817-1840. doi: 10.1007/s00204-016-1744-5.
10) Trushina, E. N. et al. 2007. Influence of Spirulina and Selen-Spirulina on some indexes of rat's immune status. Vopr Pitan. 76(2):21-5.
11) Mao, T. K. et al. 2005. Effects of Spirulina-based supplements on cytokine production from allergic rhinitis patients. J Med Food. 8(1):27-30. doi: 10.1089/jmf.2005.8.27.
12) Cingi, C. et al. 2008. The effects of spirulina on allergic rhinitis. Eur Arch Otorhinolaryngol. 265(10):1219-1223. doi: 10.1007/s00405-008-0642-8.
13) Parikh, P. et al. 2001. Role of Spirulina in the control of glycemia and lipidemia in type 2 diabetes mellitus. Med Food. 4(4):193-9. doi: 10.1089/10966200152744463.
14) Torres-Duran, P. V. et al. 2007. Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report. Lipids Health Dis. 6:33. doi: 10.1186/1476-511X-6-33.
15) Ionov, V. A., Basova, M. M. 2003. Use of blue-green micro-seaweed Spirulina platensis for the correction of lipid and hemostatic disturbances in patients with ischemic heart disease. Vopr Pitan. 72(6):28-31.
16) Riss, J. et al. 2007. Phycobiliprotein C-phycocyanin from Spirulina platensis is powerfully responsible for reducing oxidative stress and NADPH oxidase expression induced by an atherogenic diet in hamsters. J Agric Food Chem. 55(19):7962-7. doi: 10.1021/jf070529g.
17) Doshi, H. 2008. Bioaccumulation of heavy metals by green algae. Curr Microbiol. 56(3):246-55. doi: 10.1007/s00284-007-9070-z.
18) Jiang, Y. 2008. Detection of the hepatotoxic microcystins in 36 kinds of cyanobacteria Spirulina food products in China. Food Addit Contam. 25(7):885-94.
References Interactions
Stargrove, M. B. et al. Herb, Nutrient and Drug Interactions: Clinical Implications and Therapeutic Strategies, 1. Auflage. St. Louis, Missouri: Elsevier Health Sciences, 2008.
Gröber, U. Mikronährstoffe: Metabolic Tuning –Prävention –Therapie, 3. Auflage. Stuttgart: WVG Wissenschaftliche Verlagsgesellschaft Stuttgart, 2011.
Gröber, U. Arzneimittel und Mikronährstoffe: Medikationsorientierte Supplementierung, 3. aktualisierte und erweiterte Auflage. Stuttgart: WVG Wissenschaftliche Verlagsgesellschaft Stuttgart, 2014.
|